Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)

Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC ( to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (

The land of Genomic Opportunity: Microsoft Securing a Way to Provide Genomic Data to Customers Via Partnership With Illumina?


Microsoft xbox, Smartphone, Tablet, PC at home, smartwatch, cloud: Microsoft needs the Illumina sequencing machines to enable people to play with their genome (speed dating, XBox, genealogy) on a variety of MS device (Cloud included!)
Deciding on the Do's and Don'ts in "genomic entertainment" is something that needs to be done -- and by whom? Best scenario case: MS, Google, Apple. Worst scenario case (should "best" one fail to happen): rogue hackers. Major players need to set appropriate limits: this is the only way to expand growth opportunities in "genomic entertainment market" (you don't want to scare your customers away).

People will want to own their genomic data, be it to play with it or to discuss it with Physicians/Practitioners. Best way for MS to enter this B2C market and win over this mass market -- let's call it the genomic entertainment market -- is by achieving partnership with Illumina... No better solution for MS to secure a way to provide genomic data to MS products (software, hardware) than a partnership with Illumina. Sony knows very well that genomic entertainment is becoming a reality, and they already have anticipated this market trend. So have Apple, FB... And, oh, of course, customers will want a user-friendly solution, otherwise they'll turn to Apple or Google or Samsung...

Martin Reese of Omicia Inc. predicts genomic analysis will switch from 80% research in 2013 to 80% clinical in 3-5 years.

MS has never shown any interest in medical & healthcare stuff... A majority of the medical staff (generally speaking) use Apple products; not MS. But what if consumers have their genomic data on their MS device(s)? It only makes sense to say that they might want to discuss their genomic data for health reasons too. Playing and having fun with the data is one thing (genomic speed dating? xbox etc.) Next step would be: using the data for precision (personalised) medicine.

People will want to own their genomic data. When it comes to decision-making about customers' genomic data, customers will have the ultimate say; not Apple or Google or MS. Now, once this is correctly anticipated, I can't see any reason why MS should miss out on this exciting opportunity: genomic entertainment, and then: precision medicine (genomic medicine)...


1) Will Sweden buy an Illumina HiSeq X Ten? 
2) Will Department of Biotechnology, Government of India, Mohali, Punjab, team up with Illumina on some sequencing project?

3 commentaires:

Ethics, Health and Death 2.0 a dit…

Ethics, Health and Death 2.0 a dit…

Ethics, Health and Death 2.0 a dit…